Literature DB >> 379225

Attachment of polymorphonuclear leukocytes to glomeruli with immune deposits.

T Yamamoto, I Kihara, T Morita, T Oite.   

Abstract

A method for quantitative evaluation of a biological activity of immune complexes deposited in glomeruli is described. The activity reflects the activation of complement and is represented by the number of PMN attached to a glomerulus. It is possible to compare data from different individuals or different phases of glomerulonephritis. The complement component concerned is considered to be C3, activated through the classical or alternate pathway.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 379225     DOI： 10.1016/0022-1759(79)90177-7

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN： 0022-1759            Impact factor:   2.303


  5 in total

1.  Role of divalent cations in binding polymorphonuclear leucocytes to glomeruli with immune complexes.

Authors:  T Yamamoto; I Kihara; T Morita; T Oite; Y Suzuki
Journal:  Clin Exp Immunol       Date:  1980-03       Impact factor: 4.330

2.  Granulocyte adhesion to nephritic glomeruli through recognition of activated C4 and C3 in immune deposits.

Authors:  T Yamamoto; S Miyazaki; K Kawasaki; E Yaoita; I Kihara
Journal:  Experientia       Date:  1985-11-15

3.  Examination of the molecular diversity of alpha1 antitrypsin in urine: deficit of an alpha1 globulin fraction on cellulose acetate membrane electrophoresis.

Authors:  Ryoko Machii; Minoru Sakatume; Ryo Kubota; Shizuko Kobayashi; Fumitake Gejyo; Kiyoko Shiba
Journal:  J Clin Lab Anal       Date:  2005       Impact factor: 2.352

4.  Bovine serum albumin (BSA) nephritis in rats II. Histological findings and complement activation by immune complex in SHR rats.

Authors:  T Yamamoto; I Kihara; M Hara; K Kawasaki; E Yaoita
Journal:  Br J Exp Pathol       Date:  1983-12

5.  Modification of immune complexes deposited in glomeruli in tissue sections treated with sulfonized gamma-globulin.

Authors:  M Sato; H Kojima; S Koshikawa
Journal:  Clin Exp Immunol       Date:  1986-06       Impact factor: 4.330
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.